WEBULL
WebtradeDownload

Envista (NVST) Stock Could Be Reasonable Given Its Cash Flow Upside

Simply Wall St · 3d ago

Envista Holdings has delivered a strong 1 year share price gain, yet over 5 years holders have seen a sizeable decline, which raises a straightforward question for anyone looking at the stock today. Are the cash flows that Envista can generate over time enough to support where the share price now sits?

  • The stock is down 41.8% over 5 years, so long term holders have real capital at risk if the underlying cash flows do not eventually line up with the current valuation.
  • Recent earnings strength and higher forward profit expectations can reshape views on how much cash the business might produce and when those inflows arrive.
  • If you'd rather focus on earnings, this one's for you. See what Envista Holdings's 6.3x P/E says about the price.

For investors, the debate is whether Envista's current share price is justified by the cash flows implied by a Discounted Cash Flow (DCF) view of the business.

If you want a wider lens on businesses where valuation rests on what their future cash flows can support, a focused stock screen using the 42 high quality undervalued stocks is a practical next step.

Is Envista Holdings a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here looks at the cash Envista Holdings might generate for shareholders and pulls those future dollars back into today’s terms. Envista is currently producing last twelve month free cash flow of about $254.6 million, and analysts see that rising into the low to mid $300 million range over the next several years, with growth rates that gradually cool rather than shoot higher.

The DCF output suggests those projected cash streams support an intrinsic value that sits substantially above the current share price of $24.96. Envista’s strong Q3 2026 results and raised full year guidance are used in the model as part of the basis for ongoing free cash flow growth rather than a flat profile. For readers who want to see how those assumptions translate into a per share estimate, the full Discounted Cash Flow (DCF) breakdown is available here. Find out what Envista Holdings could be worth using our Discounted Cash Flow (DCF) estimate.

The Envista Holdings Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Envista Holdings pick up where the DCF puzzle leaves off and explain which future paths for revenue growth, profit margins and earnings power would need to occur for the shares to appear meaningfully undervalued or overvalued relative to today’s price. Rather than giving a single figure, they break down the assumptions Envista Holdings' valuation depends on so you can track how real-world developments compare with that story over time on the Community page.

Envista Holdings splits the community, with one camp seeing meaningful upside in the dental platform and another arguing most of the value is already in the price.

Bull case: 27% undervalued

"Envista Holdings is gradually shifting a larger share of diagnostics revenue toward software and services, which already account for 27% of that segment, and further uptake of AI tools such as DTX Studio Clinic and MagicAssist could support higher recurring revenue and structurally better net margins."

Discover why this Narrative puts Envista Holdings at 27% undervalued.

Bear case: 9% overvalued

"While Envista Holdings is investing in integrated digital workflows across imaging and treatment planning, the upcoming orthodontic and second implant volume based procurement rounds in China with implied 40% to 50% and 10% to 15% price cuts risk muting the earnings contribution from those digital ecosystems as lower reimbursement flows through to revenue and net margins."

Explore why this Narrative puts Envista Holdings at 9% overvalued.

One more Envista Holdings check that belongs beside the valuation work

Before treating Envista Holdings as just a cash flow story and a price chart, it is worth seeing what issues our broader fundamental checks have flagged for closer review. Take a closer look at 1 major warning sign before settling on a valuation.